A Study to Assess the Pharmacokinetics of Methotrexate Given With and Without AZD9056 in Rheumatoid Arthritis Patients

NCT00920608 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: AZD9056
DRUG: Methotrexate

Sponsor

AstraZeneca